Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.
Theocharides A, Gisslinger H, De Stefano V, Accurso V, Iurlo A, Devos T, Egyed M, Lippert E, Delgado RG, Cantoni N, Dahm AEA, Sotiropoulos D, Houtsma E, Smyth A, Iqbal A, Di Matteo P, Zuurman M, Te Boekhorst PAW. Theocharides A, et al. Among authors: egyed m. Eur J Haematol. 2024 Mar;112(3):379-391. doi: 10.1111/ejh.14124. Epub 2023 Oct 30. Eur J Haematol. 2024. PMID: 37899734
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Verstovsek S, Gerds AT, Vannucchi AM, Al-Ali HK, Lavie D, Kuykendall AT, Grosicki S, Iurlo A, Goh YT, Lazaroiu MC, Egyed M, Fox ML, McLornan D, Perkins A, Yoon SS, Gupta V, Kiladjian JJ, Granacher N, Lee SE, Ocroteala L, Passamonti F, Harrison CN, Klencke BJ, Ro S, Donahue R, Kawashima J, Mesa R; MOMENTUM Study Investigators. Verstovsek S, et al. Among authors: egyed m. Lancet. 2023 Jan 28;401(10373):269-280. doi: 10.1016/S0140-6736(22)02036-0. Lancet. 2023. PMID: 36709073 Clinical Trial.
[Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
Matolcsy A, Borbényi Z, Demeter J, Egyed M, Fekete S, Földi J, Gergely L, Kajtár P, Kelényi G, Kiss A, László T, Lehoczky D, Losonczy H, Nagy M, Pál K, Pálóczy K, Radványi G, Semsei I, Varga G, Udvardy M. Matolcsy A, et al. Among authors: egyed m. Orv Hetil. 2000 Jun 18;141(25):1403-6. Orv Hetil. 2000. PMID: 10934884 Hungarian.
[Cytogenetic and molecular monitoring of chronic myeloid leukemia].
Kajtár B, Méhes G, Jaksó P, Kereskai L, Iványi JL, Losonczy H, Egyed M, Tóth P, Tóth A, Gasztonyi Z, Dömötör M, Pajor L. Kajtár B, et al. Among authors: egyed m. Orv Hetil. 2006 May 28;147(21):963-70. Orv Hetil. 2006. PMID: 16812971 Review. Hungarian.
[Complex analysis of prognostic factors in chronic lymphocytic leukemia].
Kajtár B, Jáksó P, Kereskai L, Lacza A, Méhes G, Bodnár MA, Dombi JP, Gasztonyi Z, Egyed M, Iványi JL, Kovács G, Marton E, Palaczki A, Petz S, Tóth P, Sziládi E, Losonczy H, Pajor L. Kajtár B, et al. Among authors: egyed m. Orv Hetil. 2007 Apr 22;148(16):737-43. doi: 10.1556/OH.2007.27943. Orv Hetil. 2007. PMID: 17437950 Hungarian.
145 results